Intrinsic Value of S&P & Nasdaq Contact Us

RadNet, Inc. RDNT NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
49/100
2/7 Pass
SharesGrow Intrinsic Value
$442.83
+660.6%
Analyst Price Target
$92.00
+58%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

RadNet, Inc. (RDNT) has a negative trailing P/E of -221.4, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 92.2 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -0.45%, forward earnings yield 1.09%. PEG 2.51.

Criteria proven by this page:

  • VALUE (60/100, Pass) — analyst target implies upside (+58%).
  • Forward P/E 92.2 — analysts expect a return to profitability with estimated EPS of $0.63 for FY2026.
  • PEG Ratio 2.51 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield -0.45% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 1.09% as earnings recover.
  • Analyst consensus target $92.00 (+58% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 49/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
49/100
SG Score
View full scorecard →
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
24/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — RDNT

Valuation Multiples
P/E (TTM)-221.4
Forward P/E92.2
PEG Ratio2.51
Forward PEG2.51
P/B Ratio3.79
P/S Ratio2.09
EV/EBITDA21.1
Per Share Data
EPS (TTM)$-0.25
Forward EPS (Est.)$0.63
Book Value / Share$18.03
Revenue / Share$27.13
FCF / Share$-2.37
Yields & Fair Value
Earnings Yield-0.45%
Forward Earnings Yield1.09%
Dividend Yield0.00%
SharesGrow IV$442.83 (+660.6%)
Analyst Target$92.00 (+58%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 41.3 -3.71 6.15 0.34 0.16%
2017 8,933.9 -89.96 7.69 0.51 -
2018 15.2 0.00 3.85 0.50 -
2019 68.3 -2.29 6.65 0.87 -
2020 -67.1 0.42 6.01 0.93 -
2021 63.9 -0.24 6.91 1.20 -
2022 99.5 -1.67 3.18 0.74 -
2023 726.2 -9.71 3.51 1.37 -
2024 1,826.3 -90.19 5.65 2.79 -
2025 -287.6 0.38 4.92 2.63 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.15 $884.54M $7.23M 0.8%
2017 $0.00 $922.19M $53K 0%
2018 $0.66 $975.15M $32.24M 3.3%
2019 $0.47 $1.15B $23.44M 2%
2020 $-0.03 $1.07B $-1.75M -0.2%
2021 $0.83 $1.32B $44.32M 3.4%
2022 $0.59 $1.43B $33.61M 2.4%
2023 $0.05 $1.62B $3.04M 0.2%
2024 $0.04 $1.83B $2.79M 0.2%
2025 $-0.25 $2.04B $-18.65M -0.9%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.63 $0.39 – $0.85 $2.46B $2.43B – $2.49B 3
2027 $1.01 $0.80 – $1.22 $2.72B $2.65B – $2.79B 3
2028 $1.18 $1.13 – $1.23 $3.03B $3.03B – $3.03B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message